Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÇağlar, İsmail Çağatay
dc.contributor.authorKocamış, Sücattin İlker
dc.contributor.authorDurmuş, Mustafa
dc.date.accessioned2019-05-13T09:04:39Z
dc.date.available2019-05-13T09:04:39Z
dc.date.issued2016
dc.identifier.citationÇaglar, Ç., Kocamış, S. İ., Durmuş, M. (2016). Isolated sixth nerve palsy after intravitreal ranibizumab injection. Cutaneous and Ocular Toxicology, 35(3), 248-250.en_US
dc.identifier.issn1556-9527
dc.identifier.urihttps://doi.org/10.3109/15569527.2015.1075998
dc.identifier.urihttps://hdl.handle.net/11491/1621
dc.description.abstractAfter intravitreal ranibizumab injection for diabetic macular edema (DME) in a 55-year-old man, the patient was admitted to our ophthalmology clinic with the complaint of diplopia. Given the results of the patient's history, physical exam, and negative magnetic resonance imaging (MRI), we believed that the patient had a sixth nerve palsy related to ranibizumab injection. To the best of our knowledge, this is the first case with isolated abducens palsy after ranibizumab injection. © 2015 Taylor & Francis.en_US
dc.language.isoeng
dc.publisherTaylor and Francis Ltden_US
dc.relation.isversionof10.3109/15569527.2015.1075998en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiplopiaen_US
dc.subjectRanibizumaben_US
dc.subjectSixth Nerve Palsyen_US
dc.titleIsolated sixth nerve palsy after intravitreal ranibizumab injectionen_US
dc.typearticleen_US
dc.relation.journalCutaneous and Ocular Toxicologyen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.authorid0000-0003-4391-2571en_US
dc.identifier.volume35en_US
dc.identifier.issue3en_US
dc.identifier.startpage248en_US
dc.identifier.endpage250en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster